+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Diagnostic morphological features of PDGFRA-mutated gastrointestinal stromal tumors: molecular genetic and histologic analysis of 60 cases of gastric gastrointestinal stromal tumors



Diagnostic morphological features of PDGFRA-mutated gastrointestinal stromal tumors: molecular genetic and histologic analysis of 60 cases of gastric gastrointestinal stromal tumors



Annals of Diagnostic Pathology 11(1): 27-33



In this study, 60 gastrointestinal stromal tumors of the stomach were analyzed to elucidate the possible relation of their morphology to the mutation status of KIT and PDGFRA genes. The patients included 27 men and 33 women with a mean age of 63.8 years (range, 12-92 years). Only 1 tumor occurred before the age of 21 years. KIT mutations were detected in 31 cases (51.7%), PDGFRA mutations in 22 cases (36.7%), and 7 cases (11.7%) were KIT and PDGFRA wild type. When the mutation status was correlated with histologic features of the tumors, epithelioid or mixed epithelioid/spindle cell pattern and mast cell infiltration were found as the most reliable signs of PDGFRA mutation. Neoplastic rhabdoid cells and multinucleated giant cells, also previously reported as features of PDGFRA-mutated gastrointestinal stromal tumors, seemed to be less specific but still helpful markers in our study. Finally, tumor-infiltrating lymphocytes and myxoid stroma do not seem to be valuable histologic signs.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 048778927

Download citation: RISBibTeXText

PMID: 17240304

DOI: 10.1016/j.anndiagpath.2006.10.002


Related references

Molecular Subtypes of KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Gastrointestinal Stromal Tumor Clinic. JAMA Oncology 2(7): 922-928, 2016

C-Kit and PDGFRA mutations and clinico-morphological features of gastrointestinal stromal tumors. Voprosy Onkologii (Stsburg). 2007; 53(6): 677-681, 2007

c-Kit and PDGFRA mutations and clinico-morphological features of gastrointestinal stromal tumors. Voprosy Onkologii 53(6): 677-681, 2008

Value of epithelioid morphology and PDGFRA immunostaining pattern for prediction of PDGFRA mutated genotype in gastrointestinal stromal tumors (GISTs). International Journal of Clinical and Experimental Pathology 6(9): 1839-1846, 2014

Chromosomal aberrations in primary PDGFRA-mutated gastrointestinal stromal tumors. Human Pathology 45(1): 85-97, 2014

Gastric stromal tumors in Carney triad are different clinically, pathologically, and behaviorally from sporadic gastric gastrointestinal stromal tumors: findings in 104 cases. American Journal of Surgical Pathology 34(1): 53-64, 2010

c-kit and PDGFRA mutations in 60 cases of gastrointestinal stromal tumors (GISTs). Beijing Da Xue Xue Bao. Yi Xue Ban 37(3): 320-324, 2005

New molecular targets beyond KIT and PDGFRA in gastrointestinal stromal tumors: present and future. Expert Opinion on Therapeutic Targets 15(7): 803-815, 2011

Molecular and genetic features of gastrointestinal stromal tumors (GIST). Revista de Gastroenterologia del Peru 32(4): 394-399, 2014

Site-dependent differential KIT and PDGFRA expression in gastric and intestinal gastrointestinal stromal tumors. Modern Pathology 20(10): 1103-1111, 2007

Analysis of mutation of the c-Kit gene and PDGFRA in gastrointestinal stromal tumors. Experimental and Therapeutic Medicine 10(3): 1045-1051, 2015

Microfluidic deletion/insertion analysis for rapid screening of KIT and PDGFRA mutations in CD117-positive gastrointestinal stromal tumors: diagnostic applications and report of a new KIT mutation. Journal of Molecular Diagnostics 9(2): 151-157, 2007

Gastrointestinal stromal tumors: definition, histological, immunohistochemical, and molecular features, and diagnostic strategy. Annales de Pathologie 25(5): 358-85; Quiz 357, 2006

Interobserver variability in histologic recognition, interpretation of KIT immunostaining, and determining MIB-1 labeling indices in gastrointestinal stromal tumors and other spindle cell tumors of the gastrointestinal tract. Applied Immunohistochemistry & Molecular Morphology 14(1): 46-51, 2006

Prognostic value of KIT/PDGFRA mutations in gastrointestinal stromal tumors: a meta-analysis. World Journal of Surgical Oncology 12: 71, 2015